简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2021-10-15 16:02 Rhizen Pharmaceuticals AG Announces First Patient Dosing in a Phase II Study of Tenalisib (RP6530) in Locally Advanced or Metastatic Breast Cancer Patients
2021-10-15 13:55 Smiths Detection confirms BioFlash detects airborne SARS-CoV-2 variants including Delta and Delta plus
2021-10-15 09:56 Zanoprima Launches Commercial Production of Its High Purity Tobacco-Free Synthetic (S) Nicotine Using Revolutionary Patented New Process
2021-10-15 09:35 New Data Presented at ECTRIMS Show Evobrutinib is First BTK Inhibitor to Demonstrate a Significant Reduction in Slowly Expanding Lesions (SEL) in Patients with RMS
2021-10-14 13:54 LianBio Appoints Jesse Wu to Board of Directors
2021-10-14 10:32 PCI Pharma Services Announces the Acquisition of LSNE to Add End-To-End Global Sterile Fill-Finish and Lyophilization Manufacturing Capabilities
2021-10-14 10:19 New Real-World MAVENCLAD® Data Show Sustained Effectiveness and Benefit on Quality-of-Life Measures in RMS Patients
2021-10-13 18:18 LianBio Appoints Susan Silbermann to Board of Directors
2021-10-13 15:54 Introducing a New Antifungal Surveillance Program: Analysis of Resistance to Antifungals (ARIA) and Expanded Mycology Services at IHMA
2021-10-13 14:33 Consensus Cloud Solutions, Inc. Completes Separation from Ziff Davis, Inc.
2021-10-13 13:48 Publication of EXALT-1 Trial in Cancer Discovery Demonstrates First AI-Supported Functional Precision Medicine Platform to Improve Cancer Treatment Outcomes
2021-10-12 19:30 DentalMonitoring Launches the ScanBoxpro, the New Version of Their Patented Device to Maximize AI-powered Control of Dental and Orthodontic Care Anywhere, Anytime
2021-10-12 18:53 Kaneka Releases PCR Test Kit for COVID-19 Variants
2021-10-12 18:10 BeiGene Announces BRUKINSA® (Zanubrutinib) Approved for Treatment of Patients with Mantle Cell Lymphoma
2021-10-12 15:17 Crown Bioscience Launches ‘3D Ex Vivo Patient Tissue Platform’ to Improve Response Predictability to Immuno-Oncology Drug Candidates
2021-10-12 15:15 Exscientia Announces Closing of $510.4 Million Aggregate Financing, Consisting of $350.4 Million Upsized Initial Public Offering With Full Exercise of Underwriters’ Option to Purchase Additional ADSs and $160.0 Million Concurrent Private Placement
2021-10-12 13:14 Vifor Pharma announces changes to its Executive Committee
2021-10-12 10:07 BeiGene Announces First Regulatory Approval in Australia for BRUKINSA® (Zanubrutinib) for Treatment of Patients with Waldenström’s Macroglobulinemia
2021-10-11 16:33 BVI Announces Investment & Collaboration with Beyeonics Vision
2021-10-11 15:41 Takeda Provides Update on TAK-994 Clinical Program

Business Wire Weibo

Press Releases

Latest Releases